Resolution of disease symptoms in patients treated with quetiapine for acute moderate to severe schizophrenia

被引:0
|
作者
Peuskens, J. [1 ]
Mourad, H. [2 ]
Kusters, J. [3 ]
Vandenhoven, G. [4 ]
机构
[1] Univ Centrum St Josef, Kortenberg, Belgium
[2] CHP, Agora Petit Bourgogne, Liege, Belgium
[3] Psychiat Ziekenhuis, Tuiden, Belgium
[4] Astrazeneca, Brussels, Belgium
关键词
D O I
10.1016/S0924-977X(07)70615-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S411 / S411
页数:1
相关论文
共 50 条
  • [1] Comorbid Moderate–Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care
    Cai-Lan Hou
    Xin-Rong Ma
    Mei-Ying Cai
    Yan Li
    Yu Zang
    Fu-Jun Jia
    Yong-Qiang Lin
    Helen F. K. Chiu
    Gabor S. Ungvari
    Brian J. Hall
    Bao-Liang Zhong
    Xiao-Lan Cao
    Yu-Tao Xiang
    Community Mental Health Journal, 2016, 52 : 921 - 926
  • [2] Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia
    Jun, T.
    Jeon, Y.
    Lee, H.
    Lee, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S486 - S486
  • [3] The effect of quetiapine on aggresive/hostility symptoms in patients with schizophrenia
    Giner, J
    Gibert, J
    Jimenez, J
    Bovio, H
    Herranz, S
    Perez, A
    Ovejero, C
    Rico-Villademoros, F
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S270 - S270
  • [4] Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia
    Lee, Kyoung-Uk
    Jeon, Yang-Whan
    Lee, Hae-Kook
    Jun, Tae-Youn
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (06) : 447 - 452
  • [5] Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care
    Hou, Cai-Lan
    Ma, Xin-Rong
    Cai, Mei-Ying
    Li, Yan
    Zang, Yu
    Jia, Fu-Jun
    Lin, Yong-Qiang
    Chiu, Helen F. K.
    Ungvari, Gabor S.
    Hall, Brian J.
    Zhong, Bao-Liang
    Cao, Xiao-Lan
    Xiang, Yu-Tao
    COMMUNITY MENTAL HEALTH JOURNAL, 2016, 52 (08) : 921 - 926
  • [6] MODERATE TO SEVERE DEPRESSIVE SYMPTOMS IN FIRST EPISODE SCHIZOPHRENIA
    Cotton, Sue M.
    Lambert, Martin
    Schimmelmann, Benno
    Mackinnon, Andrew
    Gleeson, John
    Berk, Michael
    McGorry, Patrick D.
    Conus, Philippe
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A28 - A29
  • [7] Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia
    Sirota, Pinkhas
    Pannet, Irit
    Koren, Ady
    Tchernichovsky, Eieonora
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (04) : 227 - 234
  • [8] Autonomic symptoms in patients with moderate and severe chronic obstructive pulmonary disease
    Mohammed, Jibril
    Derom, Eric
    De Wandele, Inge
    Rombaut, Lies
    Calders, Patrick
    ACTA CLINICA BELGICA, 2018, 73 (03) : 182 - 190
  • [9] Expression of the inflammatory cytokine mRNA in patients with schizophrenia treated with quetiapine
    Kawashige, S.
    Kikuyama, H.
    Tsutsumi, A.
    Kanazawa, T.
    Hori, T.
    Nishiguchi, M.
    Hokyo, A.
    Koh, J.
    Yoneda, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S539 - S539
  • [10] Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms
    Michael Riedel
    Ilja Spellmann
    Martin Strassnig
    Anette Douhet
    Sandra Dehning
    Markus Opgen-Rhein
    Rosamaria Valdevit
    Rolf R. Engel
    Nikolaus Kleindienst
    Norbert Müller
    Hans-Jürgen Möller
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 360 - 370